Original news and analysis on international IP policy
Though the WHO is among the recipients of EU contributions, support should be scaled up now that the WHO fears program cuts because of a persistent funding crisis. Revenues from a Financial Transaction Tax would be a resource for the EU to partly allocate for WHO needs, writes Daniele Dionisio.
The GAVI Alliance launched a mid-term report this week showing that the public-private partnership is on track to immunise more than 250 million children by 2015 and prevent some four million deaths. GAVI’s CEO said it uses multiple tools to help reduce prices of vaccine and that intellectual property rights do not pose a serious threat to its success.
The World Health Organization is putting the finishing touches on an implementation plan for industry's financial participation in the global influenza preparedness strategy. This week the advisory group met to discuss a draft plan presented by the WHO secretariat, which should now come up with a revised version for implementation in early 2014, according to the chair of the advisory group.
The US Chamber of Commerce's Global Intellectual Property Center organised a panel during the World Trade Organization Public Forum last week to explore what industry sees as challenges of trade in the digital age. Three panellists presented concerns - mainly counterfeiting - and solutions they have put in place to address such challenges.
A closed-door working group under the World Health Organization will meet next week to continue working out details of a plan for companies to pay for the right to use influenza virus strains to potentially develop patented treatments.
The World Health Organization, the United Nations health agency in persistent financial straits, has announced it must begin charging a fee to manufacturers seeking prequalification of their vaccines and diagnostics. The announcement stirred concern among public health advocates that it might have a negative effect for procurement and access to life-saving medicines.
The World Health Organization last week released a new report highlighting how global and local research can help design a system for universal health coverage tailored to each country’s specific needs.
The Medicines Patent Pool today announced an agreement with Swiss pharmaceutical company Roche to increase access and reduce the cost of a medicine that treats a viral infection in people with weakened immune systems, specifically for people living with HIV.
World Health Organization members are meeting this week to advance the new international mechanism against substandard and counterfeit medicines.
Just as the world of international intellectual property law and policy is ever-changing, so are the faces within it. Below you will find an updated list of the latest people news and IP moves across international organisations, national and regional governments, nonprofit organisations, and the private sector, from the first half of this year.
Decline in pharmaceutical research and development productivity is one of the main challenges addressed in the 2013 edition of the World Health Organization report, Priority Medicines for Europe and the World. Whether the decline in pharmaceutical R&D is due to R&D depletion, overly strict regulatory hurdles, or the current pharmaceutical business model remains unanswered.
The themes of innovation, collaboration, and policy coherence shared the spotlight during panel discussions at the 5 July technical symposium on Medical Innovation: Changing Business Models. The event was jointly hosted by the World Health Organization, World Intellectual Property Organization, and World Trade Organization.